What's breaking now, across thousands of outlets.
The next weight-loss drugs to watch are CagriSema, retatrutide and aleniglipron, three obesity candidates at different stages of testing and FDA review, and only one has been filed
We haven't written up this one. Quartz has the full story — the link below goes straight to it.
Missouri attorney general warned Eli Lilly to discontinue requiring hospitals to provide claims data to receive discounted medicines under 340B program
As Pinktober brings renewed attention to breast cancer awareness, a women-led motorcycle rally took to the streets of Karachi last Sunday, bringing together female riders, organisers and a medical…
Civil society groups and health workers in Akwa Ibom say stigma, cultural barriers, poor facilities and confidentiality concerns are keeping vulnerable residents from accessing HIV, TB and malaria…
Civil society groups and health workers in Akwa Ibom say stigma, cultural barriers, poor facilities and confidentiality concerns are keeping vulnerable residents from accessing HIV, TB and malaria…
For cancer patients in India, the struggle to stay alive is as much about the disease as about the arithmetic of fighting it. Experts call the government’s price caps a tokenistic, short-term measure.
